STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

CorVel Announces Revenues and Earnings

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags

CorVel (NASDAQ: CRVL) reported strong financial results for Q3 FY2025. Revenue increased 13% to $228 million compared to $202 million in Q3 FY2024. Earnings per share rose 39% to $0.46 from $0.33 year-over-year.

For the nine months ended December 31, 2024, revenues reached $664 million, up from $588 million in the same period of 2023. Gross profit increased 25% to $52.9 million, achieving a 23.2% gross margin. The company maintained a strong financial position with $163 million in cash and no borrowings, while repurchasing $9.6 million of common stock during the quarter.

The company implemented generative-AI functionality to enhance document processing and claim milestone identification, with plans for further improvements to their integrated communication platform. CorVel also noted increasing demand for medical cost savings solutions through their CERIS platform.

Loading...
Loading translation...

Positive

  • Revenue growth of 13% YoY to $228 million in Q3
  • EPS increased 39% YoY to $0.46
  • Gross profit up 25% to $52.9 million with 23.2% margin
  • Strong cash position of $163 million with zero debt
  • Active share repurchase program with $9.6 million buyback in Q3

Negative

  • None.

News Market Reaction 1 Alert

+7.47% News Effect

On the day this news was published, CRVL gained 7.47%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

FORT WORTH, Texas, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended December 31, 2024. Revenues for the quarter were $228 million, an increase from $202 million in the December quarter of 2023. Earnings per share for the quarter were $0.46, compared to $0.33 in the same quarter of the prior year. Revenues for the nine months ended December 31, 2024 were $664 million, an increase from $588 million during the nine months ended December 31, 2023. Earnings per share for the nine months ended December 31, 2024 were $1.32, compared to $1.09 during the nine months ended December 31, 2023. The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024.

Third Quarter Fiscal Year 2025 Highlights 

  • Revenue increased 13% to $228 million, compared to the third quarter of fiscal year 2024.
  • Gross profit increased 25% to $52.9 million, at 23.2% gross margin, compared to the third quarter of fiscal year 2024 gross profit of $42.2 million.
  • Diluted earnings per share increased 39% to $0.46, compared to the third quarter of fiscal year 2024 diluted earnings per share of $0.33.
  • Exited the quarter with $163 million cash, cash equivalents, and no borrowings.
  • The Company repurchased $9.6 million of common stock during the quarter.

A key to CorVel’s success and differentiation in technological innovation is the development team’s structure, the depth and tenure of the employees, and the lack of impedance in translating business needs into the development and implementation of functioning systems. Due to the depth and strength of the IT team, system updates, and new features are released weekly, which enables rapid progress on enhancements and advancements in automation and innovation. In the December quarter, generative-AI-based functionality was released to streamline document processing and identify claim milestones, and improvements are planned to enhance the integrated communication platform. These enhancements can optimize outcomes, improve the experience of injured workers, and make day-to-day tasks easier, which allows CorVel professionals to focus on higher-level activities.

During the quarter in the healthcare market, the persistent upward trend of medical costs is causing Administrative Services Only, ASO, customers to seek additional medical savings and greater cost efficiency in claims. CERIS is ideally equipped to solve the growing demand by offering multiple audits and lowering claim thresholds. With substantial expertise in prepay, CERIS is able to accommodate ASOs and Payers with the tools needed to reduce medical spend without additional administrative overhead.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, improved productivity resulting from automation and augmentation across enterprise business systems. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement results of operations and financial condition is greater than our initial assessment. The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2024, and the Company’s Quarterly Report on Form 10-Q for the quarters ended June 30, 2024 and September 30, 2024. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

CorVel Corporation
Quarterly Results – Income Statement
Quarters and Nine Months Ended December 31, 2024 (unaudited) and December 31, 2023 (unaudited)

Quarter Ended December 31, 2024  December 31, 2023 
Revenues $227,973,000  $202,303,000 
Cost of revenues  175,115,000   160,143,000 
Gross profit  52,858,000   42,160,000 
General and administrative  22,058,000   19,798,000 
Income from operations  30,800,000   22,362,000 
Income tax provision  7,029,000   5,267,000 
Net income $23,771,000  $17,095,000 
Earnings Per Share:      
Basic $0.46  $0.33 
Diluted $0.46  $0.33 
Weighted Shares      
Basic  51,388,000   51,318,000 
Diluted  52,038,000   51,978,000 


Nine Months Ended December 31, 2024  December 31, 2023 
Revenues $664,075,000  $588,078,000 
Cost of revenues  512,528,000   459,788,000 
Gross profit  151,547,000   128,290,000 
General and administrative  64,043,000   55,786,000 
Income from operations  87,504,000   72,504,000 
Income tax provision  18,758,000   15,706,000 
Net income $68,746,000  $56,798,000 
Earnings Per Share:      
Basic $1.34  $1.11 
Diluted $1.32  $1.09 
Weighted Shares      
Basic  51,384,000   51,372,000 
Diluted  51,999,000   52,056,000 
         

CorVel Corporation
Quarterly Results – Condensed Balance Sheet
December 31, 2024 (unaudited) and March 31, 2024

  December 31, 2024  March 31, 2024 
Cash $162,944,000  $105,563,000 
Customer deposits  99,496,000   88,142,000 
Accounts receivable, net  106,178,000   97,108,000 
Prepaid taxes and expenses  14,543,000   11,418,000 
Property, net  91,256,000   85,892,000 
Goodwill and other assets  42,420,000   42,498,000 
Right-of-use asset, net  21,940,000   24,058,000 
Total $538,777,000  $454,679,000 
Accounts and taxes payable $16,630,000  $16,631,000 
Accrued liabilities  200,108,000   167,868,000 
Long-term lease liabilities  21,189,000   22,533,000 
Paid-in capital  246,698,000   233,632,000 
Treasury stock  (822,514,000)  (793,905,000)
Retained earnings  876,666,000   807,920,000 
Total $538,777,000  $454,679,000 


Contact: Melissa Storan
Phone: 949-851-1473
www.corvel.com

FAQ

What was CorVel's (CRVL) revenue growth in Q3 FY2025?

CorVel reported a 13% revenue growth to $228 million in Q3 FY2025, compared to $202 million in Q3 FY2024.

How much did CorVel's (CRVL) EPS increase in Q3 2024?

CorVel's earnings per share increased 39% to $0.46 in Q3 FY2025, compared to $0.33 in Q3 FY2024.

What was CorVel's (CRVL) gross profit margin in Q3 FY2025?

CorVel achieved a gross profit margin of 23.2% in Q3 FY2025, with gross profit increasing 25% to $52.9 million.

How much cash did CorVel (CRVL) spend on share repurchases in Q3 FY2025?

CorVel repurchased $9.6 million worth of common stock during Q3 FY2025.

What is CorVel's (CRVL) current cash position?

CorVel reported $163 million in cash and cash equivalents with no borrowings as of Q3 FY2025.
Corvel Corp

NASDAQ:CRVL

CRVL Rankings

CRVL Latest News

CRVL Latest SEC Filings

CRVL Stock Data

3.62B
28.81M
43.75%
54.55%
1.17%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
IRVINE